Free Trial

Lineage Cell Therapeutics (LCTX) Short Interest Ratio & Short Volume

Lineage Cell Therapeutics logo
$1.73 0.00 (0.00%)
Closing price 10/8/2025 04:10 PM Eastern
Extended Trading
$1.78 +0.05 (+2.89%)
As of 05:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lineage Cell Therapeutics Short Interest Data

Lineage Cell Therapeutics (LCTX) has a short interest of 27.75 million shares. This marks a 2.59% increase in short interest from the previous month. The short interest ratio (days to cover) is 13.2, indicating that it would take 13.2 days of the average trading volume of 1.85 million shares to cover all short positions.

Current Short Interest
27,750,000 shares
Previous Short Interest
27,050,000 shares
Change Vs. Previous Month
+2.59%
Dollar Volume Sold Short
$37.46 million
Short Interest Ratio
13.2 Days to Cover
Last Record Date
September 15, 2025
Outstanding Shares
228,360,000 shares
Percentage of Shares Shorted
12.15%
Today's Trading Volume
2,315,944 shares
Average Trading Volume
1,845,561 shares
Today's Volume Vs. Average
125%
Short Selling Lineage Cell Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

LCTX Short Interest Over Time

LCTX Days to Cover Over Time

LCTX Percentage of Float Shorted Over Time

Lineage Cell Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/202527,750,000 shares $37.46 million +2.6%N/A13.2 $1.35
8/31/202527,050,000 shares $31.65 million +1.1%16.2%11.1 $1.17
8/15/202526,760,000 shares $32.11 million -1.8%N/A10.8 $1.20
7/31/202527,240,000 shares $27.78 million -3.0%16.3%11.7 $1.02
7/15/202528,090,000 shares $28.09 million +1.3%N/A12.5 $1.00
6/30/202527,740,000 shares $25.17 million -3.5%16.6%12.8 $0.91
6/15/202528,730,000 shares $23.29 million -2.3%17.2%17.1 $0.81
5/31/202529,410,000 shares $19.44 million -1.8%17.5%20.6 $0.66
5/15/202529,960,000 shares $14.10 million -0.1%17.8%22.2 $0.47
4/30/202530,000,000 shares $14.97 million +5.5%N/A23.4 $0.50
4/15/202528,430,000 shares $12.19 million +6.7%16.9%20.2 $0.43
3/31/202526,640,000 shares $12.03 million +19.3%15.8%17.1 $0.45
3/15/202522,340,000 shares $11.62 million +1.4%13.3%12.1 $0.52
2/28/202522,030,000 shares $12.37 million +2.2%13.1%11.8 $0.56
2/15/202521,550,000 shares $0.00 +1.2%12.8%8.3 $0.00
1/31/202521,300,000 shares $0.00 -21.4%N/A8.3 $0.00
1/15/202527,110,000 shares $0.00 +4.2%N/A11.5 $0.00
12/31/202426,030,000 shares $0.00 +13.5%N/A12 $0.00
12/15/202422,940,000 shares $0.00 +25.1%N/A13.4 $0.00
11/30/202418,340,000 shares $0.00 +13.7%N/A13 $0.00
11/15/202416,130,000 shares $0.00 +1.2%N/A15.1 $0.00
10/31/202415,940,000 shares $0.00 +1.1%N/A36.8 $0.00
10/15/202415,770,000 shares $0.00 +3.6%N/A33.7 $0.00
9/30/202415,220,000 shares $0.00 -2.6%N/A32 $0.00
9/15/202415,630,000 shares $0.00 -1.2%N/A27.1 $0.00
8/31/202415,820,000 shares $0.00 +2.0%N/A25 $0.00
8/15/202415,510,000 shares $0.00 +6.5%N/A19.5 $0.00
7/31/202414,560,000 shares $0.00 No ChangeN/A16.6 $0.00
7/15/202414,560,000 shares $0.00 +12.7%N/A15.3 $0.00
6/30/202412,920,000 shares $0.00 No ChangeN/A12.8 $0.00
6/15/202412,920,000 shares $0.00 +5.4%N/A12 $0.00
5/31/202412,260,000 shares $0.00 -0.9%N/A11 $0.00
5/15/202412,370,000 shares $0.00 +13.5%N/A12.2 $0.00
4/30/202410,900,000 shares $0.00 +3.0%N/A11 $0.00
4/15/202410,580,000 shares $0.00 +1.7%N/A11.2 $0.00
3/31/202410,400,000 shares $0.00 +4.2%N/A11.4 $0.00
3/15/20249,980,000 shares $0.00 +3.7%N/A11.9 $0.00
2/29/20249,620,000 shares $0.00 -4.2%N/A11.5 $0.00
2/15/202410,040,000 shares $0.00 +18.7%N/A13.1 $0.00
1/31/20248,460,000 shares $0.00 +7.4%N/A11.3 $0.00
1/15/20247,880,000 shares $0.00 +13.5%N/A12.7 $0.00
12/31/20236,940,000 shares $0.00 +12.9%N/A11.3 $0.00
12/15/20236,150,000 shares $0.00 -3.5%N/A11.9 $0.00
11/30/20236,370,000 shares $0.00 +6.0%N/A13.4 $0.00
11/15/20236,010,000 shares $0.00 -2.3%N/A13.3 $0.00
10/31/20236,150,000 shares $7.01 million -2.5%N/A14.1 $1.14
10/15/20236,310,000 shares $0.00 +1.5%N/A14.2 $0.00
9/30/20236,220,000 shares $0.00 No ChangeN/A13.2 $0.00
9/15/20236,220,000 shares $0.00 +0.7%N/A13.3 $0.00
8/31/20236,180,000 shares $0.00 +1.0%N/A8.1 $0.00
8/15/20236,120,000 shares $0.00 -0.3%N/A7.8 $0.00
7/31/20236,140,000 shares $0.00 -3.6%N/A8.1 $0.00
7/15/20236,370,000 shares $0.00 -1.1%N/A8.6 $0.00
6/30/20236,440,000 shares $0.00 +19.0%N/A9 $0.00
6/15/20235,410,000 shares $0.00 +13.7%N/A7.7 $0.00
5/31/20234,760,000 shares $0.00 +11.5%N/A12.7 $0.00
5/15/20234,270,000 shares $0.00 -6.0%N/A12.8 $0.00
4/30/20234,540,000 shares $0.00 -0.2%N/A12.9 $0.00
4/15/20234,550,000 shares $0.00 +2.9%N/A13 $0.00
3/31/20234,420,000 shares $0.00 +7.3%N/A12.9 $0.00
3/15/20234,120,000 shares $0.00 -1.2%N/A10.9 $0.00
2/28/20234,170,000 shares $0.00 -0.5%N/A11.2 $0.00
2/15/20234,190,000 shares $0.00 +1.0%N/A11.3 $0.00
1/31/20234,150,000 shares $0.00 -0.2%N/A10.5 $0.00
1/15/20234,160,000 shares $0.00 +2.0%N/A10.9 $0.00
12/30/20224,080,000 shares $0.00 -4.0%N/A10.5 $0.00
12/15/20224,250,000 shares $0.00 -1.6%N/A12.5 $0.00
11/30/20224,320,000 shares $0.00 +0.7%N/A13.4 $0.00
11/15/20224,290,000 shares $0.00 -0.2%N/A13.8 $0.00
10/31/20224,300,000 shares $0.00 -3.4%N/A15 $0.00
10/15/20224,450,000 shares $0.00 -0.5%N/A13.9 $0.00
9/30/20224,470,000 shares $0.00 +0.7%N/A14.2 $0.00
9/15/20224,440,000 shares $0.00 -2.8%N/A6.6 $0.00
8/31/20224,570,000 shares $0.00 +2.0%N/A6 $0.00
8/15/20224,480,000 shares $0.00 -7.4%N/A5.3 $0.00
7/31/20224,840,000 shares $0.00 -2.6%N/A5.3 $0.00
7/15/20224,970,000 shares $0.00 -9.3%N/A5.3 $0.00
6/30/20225,480,000 shares $0.00 -38.6%N/A5.4 $0.00
6/15/20228,930,000 shares $0.00 -7.8%N/A8.9 $0.00
5/31/20229,690,000 shares $0.00 -8.3%N/A14 $0.00
5/15/202210,570,000 shares $0.00 +5.0%N/A15.7 $0.00
4/30/202210,070,000 shares $0.00 +12.5%N/A15.7 $0.00
4/15/20228,950,000 shares $0.00 -3.8%N/A13.3 $0.00
3/31/20229,300,000 shares $0.00 +1.8%N/A13 $0.00
3/15/20229,140,000 shares $0.00 +5.2%N/A10.3 $0.00
2/28/20228,690,000 shares $0.00 -3.3%N/A7.6 $0.00
2/15/20228,990,000 shares $0.00 +4.9%N/A7.3 $0.00
1/31/20228,570,000 shares $13.54 million +0.2%N/A6.9 $1.58
1/15/20228,550,000 shares $0.00 +7.7%N/A6.9 $0.00
12/31/20217,940,000 shares $0.00 -23.3%N/A7.1 $0.00
12/15/202110,350,000 shares $0.00 +23.7%N/A9.8 $0.00
11/30/20218,370,000 shares $18.92 million +9.3%N/A10.5 $2.26
11/15/20217,660,000 shares $0.00 -6.6%N/A10.8 $0.00
10/29/20218,200,000 shares $18.70 million No ChangeN/A12.1 $2.28
10/15/20218,200,000 shares $0.00 -6.8%N/A12.6 $0.00
9/30/20218,800,000 shares $0.00 +14.3%N/A12.4 $0.00
9/15/20217,700,000 shares $0.00 +1.1%N/A7.4 $0.00
8/31/20217,620,000 shares $0.00 -6.6%N/A7.2 $0.00
8/13/20218,160,000 shares $0.00 -8.0%N/A6.6 $0.00
7/30/20218,870,000 shares $0.00 -2.0%N/A6.8 $0.00
7/15/20219,050,000 shares $0.00 +6.2%5.6%6.4 $0.00
6/30/20218,520,000 shares $0.00 +37.2%5.3%6 $0.00
6/15/20216,210,000 shares $0.00 -3.1%3.9%5.4 $0.00
5/28/20216,410,000 shares $0.00 +2.7%4.0%5.4 $0.00
5/14/20216,240,000 shares $0.00 +13.0%N/A5.2 $0.00
4/30/20215,520,000 shares $0.00 +1.7%N/A3.7 $0.00
4/15/20215,430,000 shares $13.68 million +1.9%N/A3.5 $2.52
3/31/20215,330,000 shares $13.86 million +25.4%N/A2.9 $2.60
3/15/20214,250,000 shares $10.24 million +10.4%N/A2.2 $2.41
2/26/20213,850,000 shares $9.09 million -14.6%2.6%2 $2.36
2/12/20214,510,000 shares $10.19 million -2.0%3.0%2.6 $2.26
1/29/20214,600,000 shares $11.27 million -23.1%3.1%2.9 $2.45
1/15/20215,980,000 shares $17.46 million +7.4%4.0%4.2 $2.92
12/31/20205,570,000 shares $9.69 million -10.7%3.7%4.9 $1.74
12/15/20206,240,000 shares $11.42 million -12.9%4.2%6.1 $1.83
11/30/20207,160,000 shares $10.02 million +1.0%4.8%8.2 $1.40
11/15/20207,090,000 shares $10.42 million -10.8%4.8%8.7 $1.47
10/30/20207,950,000 shares $9.22 million -2.6%5.3%10.6 $1.16
10/15/20208,160,000 shares $11.18 million +12.4%5.5%10.7 $1.37

LCTX Short Interest - Frequently Asked Questions

What is Lineage Cell Therapeutics' current short interest?

Short interest is the volume of Lineage Cell Therapeutics shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 27,750,000 shares of LCTX short. Learn More on Lineage Cell Therapeutics' current short interest.

What is a good short interest ratio for Lineage Cell Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LCTX shares currently have a short interest ratio of 13.0. Learn More on Lineage Cell Therapeutics's short interest ratio.

Is Lineage Cell Therapeutics' short interest increasing or decreasing?

Lineage Cell Therapeutics saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 27,750,000 shares, an increase of 2.6% from the previous total of 27,050,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Lineage Cell Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lineage Cell Therapeutics: Biohaven Ltd. (12.47%), Structure Therapeutics Inc. Sponsored ADR (12.03%), Avadel Pharmaceuticals PLC. (10.75%), Aurinia Pharmaceuticals Inc (7.56%), AbCellera Biologics Inc. (19.69%), Schrodinger, Inc. (14.29%), Janux Therapeutics, Inc. (15.35%), Arcus Biosciences, Inc. (16.66%), Ardelyx, Inc. (8.20%), Syndax Pharmaceuticals, Inc. (26.86%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks.

What does it mean to sell short Lineage Cell Therapeutics stock?

Short selling LCTX is an investing strategy that aims to generate trading profit from Lineage Cell Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Lineage Cell Therapeutics?

A short squeeze for Lineage Cell Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LCTX, which in turn drives the price of the stock up even further.

How often is Lineage Cell Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LCTX, twice per month. The most recent reporting period available is September, 15 2025.




This page (NYSEAMERICAN:LCTX) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners